Beruflich Dokumente
Kultur Dokumente
HSOA Journal of
Pulmonary Medicine & Respiratory Research
Research Article
• Page 2 of 4 •
Table 1: General characteristics and main differences between the group of subjects Luis Javier Nannini received fees as speaker and advisory board
that did not use SABA as rescue medication and the control group of subjects that did for AstraZeneca, Argentina SA and Novartis Argentina SA. Nadia S
use SABA. Daily maximum rescue medication for NO SABA group signified others Neumayer, Octavio M Fernández and Daniela M Flores had no con-
agents than SABA; generally preventer therapy.
flict of interest to declare.
• Page 3 of 4 •
5. Global Initiative for asthma (2018) Global strategy for asthma manage-
References ment and prevention, 2018.
1. Ebmeier SJ, Thayabaran D, Braithwaite I, Benamara C, Weatherall M, et 6. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, et al. (2004) De-
al. (2017) Trends in international asthma mortality rates. Lancet 390: 935- velopment of the Asthma Control Test: a survey for assessing asthma con-
945. trol. J Allergy Clin Immunol 113: 59-65.
2. GBD 2015 Chronic Respiratory Disease Collaborators (2017) Global, re- 7. Rodrigo GJ, Arcos JP, Nannini LJ, Neffen H, Gonzalez Broin M, et al.
gional, and national deaths, prevalence, disability-adjusted life years, and (2008) Reliability and factor analysis of the Spanish version of the Asthma
years lived with disability for chronic obstructive pulmonary disease and Control Test. Ann Allergy Asthma Immunol 100: 17-22.
asthma, 1990-2015: a systematic analysis for the Global Burden of Disease
8. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005)
Study 2015. Lancet Respir Med 5: 691-706.
Standardisation of spirometry. ATS/ERS Task Force: standarisation of lung
function testing. Eur Respir J 26: 319-338.
3. Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, et al. (1994) A cohort
analysis of excess mortality in asthma and the use of inhaled beta-agonists. 9. Nannini LJ, Neumayer NS (2018) Treatment Step 1 for Asthma Should
Am J Respir Crit Care Med 149: 604-610. Not Be Left Blank, and SABA-Only Might Not Be a Treatment Step 1
Option for Asthma. Respiration 95: 212-214.
4. Nannini LJ (2018) Overreliance link between asthmatic subjects and
short-acting β2 agonists. Pulm Pharm Ther 50: 80-81. 10. Nannini LJ (2019) Treat to target approach for asthma. J Asthma 23: 1-4.
Journal of Gastroenterology & Hepatology Research Sports Medicine and Injury Care Journal
Journal of Gerontology & Geriatric Medicine International Journal of Case Reports and Therapeutic Studies
Herald Scholarly Open Access, 2561 Cornelia Rd, #205, Herndon, VA 20171, USA.
Tel: +1 202-499-9679; E-mail: info@heraldsopenaccess.us
http://www.heraldopenaccess.us/